| Product Code: ETC5242338 | Publication Date: Nov 2023 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Brunei aminoglycosides import market in 2024 continued to be dominated by key exporting countries such as Malaysia, Indonesia, India, Vietnam, and the United States of America. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market structure. The compound annual growth rate (CAGR) from 2020 to 2024 experienced a steep decline at -46.46%, with a significant decrease in growth rate from 2023 to 2024 at -76.4%. These figures suggest a challenging landscape for aminoglycosides importers in Brunei, potentially influenced by various market dynamics impacting the industry.


The Aminoglycosides market in Brunei Darussalam is projected to grow at a stable growth rate of 1.07% by 2027, highlighting the country's increasing focus on advanced technologies within the Asia region, where China holds the dominant position, followed closely by India, Japan, Australia and South Korea, shaping overall regional demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Aminoglycosides Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Aminoglycosides Market - Industry Life Cycle |
3.4 Brunei Aminoglycosides Market - Porter's Five Forces |
3.5 Brunei Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Brunei Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Brunei Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Brunei Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Brunei |
4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating severe infections |
4.2.3 Rising demand for advanced healthcare facilities and medications in Brunei |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for the use of aminoglycosides |
4.3.2 Potential side effects and toxicity associated with aminoglycoside use |
4.3.3 Competition from alternative antibiotic classes in the market |
5 Brunei Aminoglycosides Market Trends |
6 Brunei Aminoglycosides Market Segmentations |
6.1 Brunei Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Brunei Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.3 Brunei Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.4 Brunei Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.5 Brunei Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.6 Brunei Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.7 Brunei Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Brunei Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Brunei Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Brunei Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Brunei Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Brunei Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Brunei Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Brunei Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Brunei Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Brunei Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Brunei Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Brunei Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Brunei Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Brunei Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Brunei Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Brunei Aminoglycosides Market Import-Export Trade Statistics |
7.1 Brunei Aminoglycosides Market Export to Major Countries |
7.2 Brunei Aminoglycosides Market Imports from Major Countries |
8 Brunei Aminoglycosides Market Key Performance Indicators |
8.1 Rate of prescription of aminoglycosides by healthcare providers in Brunei |
8.2 Number of hospitals and clinics stocking aminoglycosides in their inventory |
8.3 Patient adherence and compliance to aminoglycoside treatment regimens |
9 Brunei Aminoglycosides Market - Opportunity Assessment |
9.1 Brunei Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Brunei Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Brunei Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Brunei Aminoglycosides Market - Competitive Landscape |
10.1 Brunei Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Brunei Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |